Contact Person: Peter Gregson, CEO Contact Information: Halifax, Nova Scotia Phone: 902.494.2175 Innovacorp is an investor in Coeur Metrics Inc.

Coeur Metrics is a developer of innovative medical devices. The company’s premier product detects and assesses heart disease.

Heart disease is one of the most frequent causes of death and illness, and requires expensive acute treatment. Most existing tools for assessing heart disease are invasive and are typically used in the later stages of diagnosis. Coeur Metrics’ newest device measures Cardiac Output (CO), the heart’s ability to pump blood, which is the most important measure of the heart’s health. The monitor will be an ideal pre-screening tool to identify early signs of heart disease.

Based on technology developed by Nova Scotia researchers, the new instrument promises to be a non-invasive, low cost, simple to use, safe and accurate alternative to current measurement methods.